#METABOLOMICS WORKBENCH joerghofmann_20220406_110456 DATATRACK_ID:3177 STUDY_ID:ST002140 ANALYSIS_ID:AN003501 PROJECT_ID:PR001355
VERSION             	1
CREATED_ON             	April 15, 2022, 1:34 pm
#PROJECT
PR:PROJECT_TITLE                 	Mitochondrial respiration in B lymphocytes is essential for humoral immunity by
PR:PROJECT_TITLE                 	controlling flux of the TCA cycle
PR:PROJECT_SUMMARY               	The function of mitochondrial respiration during B cell fate decisions and
PR:PROJECT_SUMMARY               	differentiation 55 remained equivocal. This study reveals that selection for
PR:PROJECT_SUMMARY               	mitochondrial fitness occurs during B 56 cell activation and is essential for
PR:PROJECT_SUMMARY               	subsequent plasma cell differentiation. By expressing a 57 mutated mitochondrial
PR:PROJECT_SUMMARY               	helicase in transitional B cells, we depleted mitochondrial DNA during 58 B cell
PR:PROJECT_SUMMARY               	maturation, resulting in reduced oxidative phosphorylation. Although no changes
PR:PROJECT_SUMMARY               	in 59 follicular B cell development were evident, germinal centers, class switch
PR:PROJECT_SUMMARY               	recombination to 60 IgG, plasma cell maturation and humoral immunity were
PR:PROJECT_SUMMARY               	diminished. Defective oxidative 61 phosphorylation led to aberrant flux of the
PR:PROJECT_SUMMARY               	tricarboxylic acid cycle and lowered the amount of 62 saturated phosphatidic
PR:PROJECT_SUMMARY               	acid. Consequently, mTOR activity and BLIMP1 induction were 63 curtailed whereas
PR:PROJECT_SUMMARY               	HIF1 _and glycolysis were amplified. Exogenous phosphatidic acid 64 increased
PR:PROJECT_SUMMARY               	mTOR activity in activated B cells. Hence, mitochondrial function is required
PR:PROJECT_SUMMARY               	and 65 selected for in activated B cells for the successful generation of
PR:PROJECT_SUMMARY               	functional plasma cells.
PR:INSTITUTE                     	University of Erlangen-Nuremberg Chair of Biochemistry
PR:LAST_NAME                     	Hofmann
PR:FIRST_NAME                    	Joerg
PR:ADDRESS                       	Staudtstr.5, Erlangen, Bavaria, 91058, Germany
PR:EMAIL                         	joerg.hofmann@fau.de
PR:PHONE                         	+49 9131 85 8260
#STUDY
ST:STUDY_TITLE                   	Mitochondrial respiration in B lymphocytes is essential for humoral immunity by
ST:STUDY_TITLE                   	controlling flux of the TCA cycle
ST:STUDY_SUMMARY                 	The function of mitochondrial respiration during B cell fate decisions and
ST:STUDY_SUMMARY                 	differentiation 55 remained equivocal. This study reveals that selection for
ST:STUDY_SUMMARY                 	mitochondrial fitness occurs during B 56 cell activation and is essential for
ST:STUDY_SUMMARY                 	subsequent plasma cell differentiation. By expressing a 57 mutated mitochondrial
ST:STUDY_SUMMARY                 	helicase in transitional B cells, we depleted mitochondrial DNA during 58 B cell
ST:STUDY_SUMMARY                 	maturation, resulting in reduced oxidative phosphorylation. Although no changes
ST:STUDY_SUMMARY                 	in 59 follicular B cell development were evident, germinal centers, class switch
ST:STUDY_SUMMARY                 	recombination to 60 IgG, plasma cell maturation and humoral immunity were
ST:STUDY_SUMMARY                 	diminished. Defective oxidative 61 phosphorylation led to aberrant flux of the
ST:STUDY_SUMMARY                 	tricarboxylic acid cycle and lowered the amount of 62 saturated phosphatidic
ST:STUDY_SUMMARY                 	acid. Consequently, mTOR activity and BLIMP1 induction were 63 curtailed whereas
ST:STUDY_SUMMARY                 	HIF1 _and glycolysis were amplified. Exogenous phosphatidic acid 64 increased
ST:STUDY_SUMMARY                 	mTOR activity in activated B cells. Hence, mitochondrial function is required
ST:STUDY_SUMMARY                 	and 65 selected for in activated B cells for the successful generation of
ST:STUDY_SUMMARY                 	functional plasma cells.
ST:INSTITUTE                     	University of Erlangen-Nürnberg
ST:DEPARTMENT                    	Division of Molecular Immunology.Universitätsklinikum Erlangen, Nikolaus
ST:DEPARTMENT                    	Fibinger Zentrum
ST:LABORATORY                    	Prof. Mielenz
ST:LAST_NAME                     	Mielenz
ST:FIRST_NAME                    	Dirk
ST:ADDRESS                       	Nikolaus-Fiebiger-Zentrum, Glückstraße 6, 91054 Erlangen
ST:EMAIL                         	dirk.mielenz@fau.de
ST:PHONE                         	++49 9131 8539105
#SUBJECT
SU:SUBJECT_TYPE                  	Cultured cells
SU:SUBJECT_SPECIES               	Mus musculus
SU:TAXONOMY_ID                   	10090
SU:GENDER                        	Male and female
#FACTORS
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	1aCre	Genotype:wildtype	Treatment=Crecontrol; RAW_FILE_NAME=1aCre_191204_PMet_BZellen.mzML
SUBJECT_SAMPLE_FACTORS           	-	2aCre	Genotype:wildtype	Treatment=Crecontrol; RAW_FILE_NAME=2aCre_191204_PMet_BZellen.mzML
SUBJECT_SAMPLE_FACTORS           	-	3aDNT	Genotype:mutant	Treatment=DNTwinkle; RAW_FILE_NAME=3aDNT_191204_PMet_BZellen.mzML
SUBJECT_SAMPLE_FACTORS           	-	4aDNT	Genotype:mutant	Treatment=DNTwinkle; RAW_FILE_NAME=4aDNT_191204_PMet_BZellen.mzML
SUBJECT_SAMPLE_FACTORS           	-	1bCre	Genotype:wildtype	Treatment=Crecontrol; RAW_FILE_NAME=1bCre_200312_PMet_BZellen.mzML
SUBJECT_SAMPLE_FACTORS           	-	2bCre	Genotype:wildtype	Treatment=Crecontrol; RAW_FILE_NAME=2bCre_200312_PMet_BZellen.mzML
SUBJECT_SAMPLE_FACTORS           	-	3bDNT	Genotype:mutant	Treatment=DNTwinkle; RAW_FILE_NAME=3bDNT_200312_PMet_BZellen.mzML
SUBJECT_SAMPLE_FACTORS           	-	4bDNT	Genotype:mutant	Treatment=DNTwinkle; RAW_FILE_NAME=4bDNT_200312_PMet_BZellen.mzML
SUBJECT_SAMPLE_FACTORS           	-	1cCre	Genotype:wildtype	Treatment=Crecontrol; RAW_FILE_NAME=1cCre_210706_PMet_BZellen.mzML
SUBJECT_SAMPLE_FACTORS           	-	2cCre	Genotype:wildtype	Treatment=Crecontrol; RAW_FILE_NAME=2cCre_210706_PMet_BZellen.mzML
SUBJECT_SAMPLE_FACTORS           	-	3cCre	Genotype:wildtype	Treatment=Crecontrol; RAW_FILE_NAME=3cCre_210706_PMet_BZellen.mzML
SUBJECT_SAMPLE_FACTORS           	-	4cDNT	Genotype:mutant	Treatment=DNTwinkle; RAW_FILE_NAME=4cDNT_210706_PMet_BZellen.mzML
SUBJECT_SAMPLE_FACTORS           	-	5cDNT	Genotype:mutant	Treatment=DNTwinkle; RAW_FILE_NAME=5cDNT_210706_PMet_BZellen.mzML
SUBJECT_SAMPLE_FACTORS           	-	6cDNT	Genotype:mutant	Treatment=DNTwinkle; RAW_FILE_NAME=6cDNT_210706_PMet_BZellen.mzML
SUBJECT_SAMPLE_FACTORS           	-	B cells_DNT_GPL analysis 1-S01_DNT	Genotype:mutant	Treatment=DNTwinkle; RAW_FILE_NAME=B cells_DNT_GPL analysis 1-S01_DNT.mzML
SUBJECT_SAMPLE_FACTORS           	-	B cells_DNT_GPL analysis 1-S02_Cre	Genotype:wildtype	Treatment=Crecontrol; RAW_FILE_NAME=B cells_DNT_GPL analysis 1-S02_Cre.mzML
SUBJECT_SAMPLE_FACTORS           	-	B cells_DNT_GPL analysis 1-S03_DNT	Genotype:mutant	Treatment=DNTwinkle; RAW_FILE_NAME=B cells_DNT_GPL analysis 1-S03_DNT.mzML
SUBJECT_SAMPLE_FACTORS           	-	B cells_DNT_GPL analysis 1-S04_Cre	Genotype:wildtype	Treatment=Crecontrol; RAW_FILE_NAME=B cells_DNT_GPL analysis 1-S04_Cre.mzML
SUBJECT_SAMPLE_FACTORS           	-	B cells_DNT_GPL analysis 1-S05_DNT	Genotype:mutant	Treatment=DNTwinkle; RAW_FILE_NAME=B cells_DNT_GPL analysis 1-S05_DNT.mzML
SUBJECT_SAMPLE_FACTORS           	-	B cells_DNT_GPL analysis 1-S06_Cre	Genotype:wildtype	Treatment=Crecontrol; RAW_FILE_NAME=B cells_DNT_GPL analysis 1-S06_Cre.mzML
SUBJECT_SAMPLE_FACTORS           	-	B cells_DNT_GPL analysis 2b-S01_Cre1	Genotype:wildtype	Treatment=Crecontrol; RAW_FILE_NAME=B cells_DNT_GPL analysis 2b-S01_Cre1.mzML
SUBJECT_SAMPLE_FACTORS           	-	B cells_DNT_GPL analysis 2b-S02_DNT2	Genotype:mutant	Treatment=DNTwinkle; RAW_FILE_NAME=B cells_DNT_GPL analysis 2b-S02_DNT2.mzML
SUBJECT_SAMPLE_FACTORS           	-	B cells_DNT_GPL analysis 2b-S03_Cre3	Genotype:wildtype	Treatment=Crecontrol; RAW_FILE_NAME=B cells_DNT_GPL analysis 2b-S03_Cre3.mzML
SUBJECT_SAMPLE_FACTORS           	-	B cells_DNT_GPL analysis 2b-S04_DNT4	Genotype:mutant	Treatment=DNTwinkle; RAW_FILE_NAME=B cells_DNT_GPL analysis 2b-S04_DNT4.mzML
SUBJECT_SAMPLE_FACTORS           	-	B cells_DNT_GPL analysis 2b-S05_Cre5	Genotype:wildtype	Treatment=Crecontrol; RAW_FILE_NAME=B cells_DNT_GPL analysis 2b-S05_Cre5.mzML
SUBJECT_SAMPLE_FACTORS           	-	B cells_DNT_GPL analysis 2b-S06_DNT6	Genotype:mutant	Treatment=DNTwinkle; RAW_FILE_NAME=B cells_DNT_GPL analysis 2b-S06_DNT6.mzML
SUBJECT_SAMPLE_FACTORS           	-	B cells_DNT_GPL analysis 2b-S07_Cre7	Genotype:wildtype	Treatment=Crecontrol; RAW_FILE_NAME=B cells_DNT_GPL analysis 2b-S07_Cre7.mzML
SUBJECT_SAMPLE_FACTORS           	-	B cells_DNT_GPL analysis 2b-S08_DNT8	Genotype:mutant	Treatment=DNTwinkle; RAW_FILE_NAME=B cells_DNT_GPL analysis 2b-S08_DNT8.mzML
SUBJECT_SAMPLE_FACTORS           	-	B cells_DNT_GPL analysis 2b-S10_DNT10	Genotype:mutant	Treatment=DNTwinkle; RAW_FILE_NAME=B cells_DNT_GPL analysis 2b-S10_DNT10.mzML
#COLLECTION
CO:COLLECTION_SUMMARY            	Both female and male mice were used in the experiments. Mice were maintained on
CO:COLLECTION_SUMMARY            	a 12-h light/dark cycle with free access to food and water according to
CO:COLLECTION_SUMMARY            	governmental rules. K320E-TWINKLE floxed mice (Baris et al., 2015) were crossed
CO:COLLECTION_SUMMARY            	to CD23 CRE mice (Kwon et al., 2008) kindly provided by Meinrad Busslinger) to
CO:COLLECTION_SUMMARY            	generate DNT animals. DNT mice used in these experiments had the genetic
CO:COLLECTION_SUMMARY            	background DNT+/- CRE+/- and CRE control mice were DNT-/- CRE+/-. The WT animals
CO:COLLECTION_SUMMARY            	used in this study were DNT-/- CRE-/- littermates. All mice were on the C57Bl/6
CO:COLLECTION_SUMMARY            	background. Isolation of primary murine cells from spleen and bone marrow Spleen
CO:COLLECTION_SUMMARY            	was transferred into cold 2 % FCS (in PBS) and gently passed through a 70 µm
CO:COLLECTION_SUMMARY            	cell strainer (BD) using the plunger of a 5 ml syringe (BD). Femur and tibia
CO:COLLECTION_SUMMARY            	were flushed with cold 2 % FCS using a 27 G cannula (BD). Cell suspensions were
CO:COLLECTION_SUMMARY            	pelleted by centrifugation at 300 x g for 5 min at 4°C. Erythrocytes were lysed
CO:COLLECTION_SUMMARY            	in red blood cell-lysis buffer (150 mM NH4Cl, 10 mM KHCO3, 100 µM EDTA) for
CO:COLLECTION_SUMMARY            	5min at room temperature. The reaction was stopped by adding cold 2% FCS before
CO:COLLECTION_SUMMARY            	centrifugation at 300 x g for 5 min at 4°C. The final cell suspensions were
CO:COLLECTION_SUMMARY            	kept in cold 2 % FCS after filtration through 30 µm mesh filter (Sysmex). In
CO:COLLECTION_SUMMARY            	vitro cultivation of primary murine B cells Splenic B cells were cultured with a
CO:COLLECTION_SUMMARY            	starting concentration of 0.5 x 106 cells/ ml in R10 medium (RPMI1640, 10 %
CO:COLLECTION_SUMMARY            	fetal calf serum (FCS), 2 mM glutamate, 1 mM sodium pyruvate, 50 U/ml penicillin
CO:COLLECTION_SUMMARY            	G, 50 μg/ml streptomycin, 50 μM β-mercaptoethanol) for 72 h at 37°C and 5%
CO:COLLECTION_SUMMARY            	CO2, supplemented with 10 µg/ml LPS. For in vitro class switch recombination
CO:COLLECTION_SUMMARY            	cells were seeded at 0.1 x 106 cells/ ml in R10 medium for 96 h, supplemented
CO:COLLECTION_SUMMARY            	with 5 ng/ml transforming growth factor , 5 nM retinoic acid, 10 µg/ml
CO:COLLECTION_SUMMARY            	anti-CD40 antibody, 10 µg/ml LPS, 100 U/ml IL4 and 10 ng/ml IL5. Ref.: Baris,
CO:COLLECTION_SUMMARY            	O.R., Ederer, S., Neuhaus, J.F., von Kleist-Retzow, J.C., Wunderlich, C.M., Pal,
CO:COLLECTION_SUMMARY            	M., WunderlichF.T., Peeva, V., Zsurka, G., Kunz, W.S., et al. (2015). Mosaic
CO:COLLECTION_SUMMARY            	Deficiency in Mitochondrial Oxidative Metabolism Promotes Cardiac Arrhythmia
CO:COLLECTION_SUMMARY            	during Aging. Cell Metab 21, 667–677.
CO:COLLECTION_PROTOCOL_FILENAME  	Bcellscoll Mielenz.pdf
CO:SAMPLE_TYPE                   	B-cells
#TREATMENT
TR:TREATMENT_SUMMARY             	in vitro activated (LPS) B cells, which cannot replicate their mitochondrial DNA
TR:TREATMENT_SUMMARY             	("DNTwinkle") resulting in impaired respiratory chain activity and oxidative
TR:TREATMENT_SUMMARY             	phosphorylation compared to Cre control B cells DTN Dominant Negative Twinkle
TR:TREATMENT_SUMMARY             	(mitochondtail Helicase)
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Glycerophospholipid analysis Glycerophospholipids (PCH, PE, PI, PS, PG, PA) in B
SP:SAMPLEPREP_SUMMARY            	cells were analyzed by Nano- Electrospray Ionization Tandem Mass Spectrometry
SP:SAMPLEPREP_SUMMARY            	(Nano-ESI-MS/MS) with direct infusion of the lipid extract (Shotgun Lipidomics):
SP:SAMPLEPREP_SUMMARY            	14 to 45 x 106 cells were homogenized in 300 μl of Milli- Q water using the
SP:SAMPLEPREP_SUMMARY            	Precellys 24 Homogenisator (Peqlab, Erlangen, Germany) at 6.500 rpm for 30 sec.
SP:SAMPLEPREP_SUMMARY            	The protein content of the homogenate was routinely determined using
SP:SAMPLEPREP_SUMMARY            	bicinchoninic acid. To 100 μl of the homogenate 400 μl of Milli-Q water,
SP:SAMPLEPREP_SUMMARY            	1.875ml of methanol/chloroform 2:1 (v/v) and internal standards (125 pmol PCH
SP:SAMPLEPREP_SUMMARY            	17:0-20:4, 132 pmol PE 17:0-20:4, 118 pmol PI 17:0-20:4, 131 pmol PS 17:0-20:4,
SP:SAMPLEPREP_SUMMARY            	62 pmol PG 17:0/20:4, 75 pmol PA 17:0/20:4 Avanti Polar Lipids) were added.
SP:SAMPLEPREP_SUMMARY            	Lipid extraction and Nano-ESI-MS/MS analysis were performed as previously
SP:SAMPLEPREP_SUMMARY            	described (Kumar et al., 2015). Endogenous glycerophospolipids were quantified
SP:SAMPLEPREP_SUMMARY            	by referring their peak areas to those of the internal standards. The calculated
SP:SAMPLEPREP_SUMMARY            	glycerophospolipid amounts were normalized to the protein content of the tissue
SP:SAMPLEPREP_SUMMARY            	homogenate. Metabolomics of phosphorylated metabolites und carbonic acids
SP:SAMPLEPREP_SUMMARY            	Experimental Setup I: Splenic B cells were isolated, activated with LPS and
SP:SAMPLEPREP_SUMMARY            	viable cells, only GFP+ for DNT, were sorted after 3 days using flow cytometry.
SP:SAMPLEPREP_SUMMARY            	Perchloric acid extraction and metabolic profiling was performed as previously
SP:SAMPLEPREP_SUMMARY            	published measured by LCMS/MS on an QTrap 3200 (Sciex) (Hofmann et al., 2011).
SP:SAMPLEPREP_SUMMARY            	Ref.: Kumar, V., Bouameur, J.E., Bar, J., Rice, R.H., Hornig-Do, H.T., Roop,
SP:SAMPLEPREP_SUMMARY            	D.R., Schwarz, N., Brodesser, 1120 S., Thiering, S., Leube, R.E., et al. (2015).
SP:SAMPLEPREP_SUMMARY            	A keratin scaffold regulates epidermal barrier 1121 formation, mitochondrial
SP:SAMPLEPREP_SUMMARY            	lipid composition, and activity. J Cell Biol 211, 1057–1075. Ref.: Hofmann,
SP:SAMPLEPREP_SUMMARY            	J., Bornke, F., Schmiedl, A., Kleine, T., and Sonnewald, U. (2011). Detecting
SP:SAMPLEPREP_SUMMARY            	functional groups of Arabidopsis mutants by metabolic profiling and evaluation
SP:SAMPLEPREP_SUMMARY            	of pleiotropic responses. 10Front Plant Sci 2, 82.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	The HPLC-system was controlled by the software Chromeleon VS 6.8 and DCMS-Link
CH:CHROMATOGRAPHY_SUMMARY        	VS1.1 (Dionex) in combination with Analyst 1.4.1 (Applied Biosystems).
CH:CHROMATOGRAPHY_SUMMARY        	Metabolites were separated on two IonPac AS11HC columns (2 × 250 mm; Dionex)
CH:CHROMATOGRAPHY_SUMMARY        	protected by an AG11HC guard column (2 × 50 mm). The elution gradient was
CH:CHROMATOGRAPHY_SUMMARY        	generated with water (eluent A) and 100 mm KOH (eluent B) within a total run
CH:CHROMATOGRAPHY_SUMMARY        	time of 80 min at a flow rate of 0.25 mL min−1 and a column temperature of
CH:CHROMATOGRAPHY_SUMMARY        	35°C as follows: 0 min, 4%; 0 to 1 min, 4%; 1 to 6 min, 15%; 6 to 12 min, 19%;
CH:CHROMATOGRAPHY_SUMMARY        	12 to 22 min, 20%; 22 to 24 min, 23%; 24 to 27 min, 35%; 27 to 37 min, 38%; 37
CH:CHROMATOGRAPHY_SUMMARY        	to 39 min, 45%; 39 to 44 min, 100%; 44 to 71 min, 100%; 71 to 76 min, 4%; and 76
CH:CHROMATOGRAPHY_SUMMARY        	to 80 min, 4% eluent B. Ref.: Hofmann, J., Bornke, F., Schmiedl, A., Kleine, T.,
CH:CHROMATOGRAPHY_SUMMARY        	and Sonnewald, U. (2011). Detecting functional groups of Arabidopsis mutants by
CH:CHROMATOGRAPHY_SUMMARY        	metabolic profiling and evaluation of pleiotropic responses. 10Front Plant Sci
CH:CHROMATOGRAPHY_SUMMARY        	2, 82.
CH:CHROMATOGRAPHY_TYPE           	Ion Chromatography
CH:INSTRUMENT_NAME               	ThermoDionexICS3000
CH:COLUMN_NAME                   	ThermoDionexAS11/AG11
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	ABI Sciex 3200 QTrap
MS:INSTRUMENT_TYPE               	QTRAP
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
MS:MS_COMMENTS                   	Mass spectrometric analysis was performed using the QTRAP 3200 (SCIEX) operated
MS:MS_COMMENTS                   	by Analyst 1.6.2. The electrospray ionization source parameters were −4,500 eV
MS:MS_COMMENTS                   	at 600°C, N2 gas pressures were 20 p.s.i. (curtaingas), 30 p.s.i. (gas1), and
MS:MS_COMMENTS                   	20 p.s.i. (gas2), and collision gas was set to medium. The dwell time for ions
MS:MS_COMMENTS                   	was 75 ms, and scan time per cycle was 3.7 s.Scan ranges were from
MS:MS_COMMENTS                   	mass-to-charge ratio 87 to 606 (precursor ions) and mass-to-charge ratio 59 to
MS:MS_COMMENTS                   	385 (product ions). Masstransitions (metabolite m/z mother ion / m/z daughter
MS:MS_COMMENTS                   	ion)recorded were as follows: UDP-glucose 565 / 323, glucose-1-phosphate 259 /
MS:MS_COMMENTS                   	79, glucose-6-phosphate 259 / 97, 3-phosphoglycerate 185 / 97, phosphoenol
MS:MS_COMMENTS                   	pyruvate 167 / 79, citrate 191 / 87, isocitrate 191 / 111, malate 133 / 71, AMP
MS:MS_COMMENTS                   	346/79, ADP 427/79, 2-oxoglutarate (aKG) 145 / 101, succinate 117 / 73, UDPNAG
MS:MS_COMMENTS                   	606/385, Itaconate 129/85, Lactat 89/43, D-glucose 179/89, fumarate 115 / 71,
MS:MS_COMMENTS                   	E4P 199/97, ATP 427/79, UDP 404/79, G16BP 339/97 The contents of metabolites
MS:MS_COMMENTS                   	were calculated based on peak areas for precursor/product ion transitions
MS:MS_COMMENTS                   	relative to standards.
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	pmol/10E6 cells
MS_METABOLITE_DATA_START
Samples	1aCre	2aCre	3aDNT	4aDNT	1bCre	2bCre	3bDNT	4bDNT	1cCre	2cCre	3cCre	4cDNT	5cDNT	5cDNT
Factors	Genotype:wildtype	Genotype:wildtype	Genotype:mutant	Genotype:mutant	Genotype:wildtype	Genotype:wildtype	Genotype:mutant	Genotype:mutant	Genotype:wildtype	Genotype:wildtype	Genotype:wildtype	Genotype:mutant	Genotype:mutant	Genotype:mutant
G1P									5	4	3	3	2	3
G6P					0	0	0	1	12	10	8	10	8	9
3PG	1	1	1	1	8	8	3	3	40	23	22	10	9	10
PEP	0	1	0	0	9	7	3	1	20	13	13	8	5	4
Cit	6	8	5	5	47	48	12	10	256	234	160	111	62	60
Icit	1	0	0	0	2	1	0	0	20	11	11	3	5	5
Mal	59	56	187	183	177	136	457	391	511	393	466	902	856	901
AMP	9	8	10	16	45	13	40	17	128	83	152	114	60	116
ADP	18	18	21	14	82	55	79	56	394	564	392	231	174	219
aKG	4	2	2	3	5	2	4	2	37	29	28	61	109	67
Succ	45	38	67	128	159	85	57	97	329	293	255	299	294	290
UDPNAG	2	3	1	1	4	4	2	1	139	123	90	39	34	25
Itaconat	3	1	1	1	3	1	0	1	25	23	21	26	42	23
Lactat	46	4	10	34	13	8	47	62	140	226	142	265	445	249
D-Glucose	91	180	69	317	157	162	274	104	28	129	37	388	794	349
Fum	15	10	30	36	13	11	50	41	132	107	149	291	219	310
E4P	0	0	0	0	2	2	5	4	96	78	63	78	112	107
ATP	4	6	3	3	112	217	76	97	2187	2650	1539	1255	1458	1197
UDP					9	10	9	4	217	250	162	452	68	69
G16BP									10	13	6	4	6	9
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	Transition measured	CAS ID
G1P	259_97	59-56-3
G6P	259_79	56-73-5
3PG	185_97	820-11-1
PEP	167_79	138-08-9
Cit	191_87	77-92-9
Icit	191_111	320-77-4
Mal	133_115	636-61-3
AMP	346_79	61-19-8
ADP	427_79	58-64-0
aKG	145_101	328-50-7
Succ	117_73	110-15-6
UDPNAG	606_385	91183-98-1
Itaconat	129_85	97-65-4
Lactat	89_43	113-21-3
D-Glucose	179_ 89	50-99-7
Fum	115_71	110-17-8
E4P	199_97	585-18-2
ATP	427_79	56-65-5
UDP	404_79	58-98-0
G16BP	339_97	305-58-8
METABOLITES_END
#END